Annual Current Liabilities
$14.18 M
+$8.57 M+152.61%
December 31, 2023
Summary
- As of February 6, 2025, CADL annual total current liabilities is $14.18 million, with the most recent change of +$8.57 million (+152.61%) on December 31, 2023.
- During the last 3 years, CADL annual current liabilities has risen by +$9.47 million (+200.95%).
- CADL annual current liabilities is now at all-time high.
Performance
CADL Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$15.27 M
+$1.27 M+9.09%
September 30, 2024
Summary
- As of February 6, 2025, CADL quarterly total current liabilities is $15.27 million, with the most recent change of +$1.27 million (+9.09%) on September 30, 2024.
- Over the past year, CADL quarterly current liabilities has increased by +$1.27 million (+9.09%).
- CADL quarterly current liabilities is now at all-time high.
Performance
CADL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CADL Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +152.6% | +9.1% |
| 3 y3 years | +200.9% | +171.9% |
| 5 y5 years | +906.0% | +171.9% |
CADL Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +164.5% | at high | +191.6% |
| 5 y | 5-year | at high | +906.0% | at high | +247.2% |
| alltime | all time | at high | +906.0% | at high | +247.2% |
Candel Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.27 M(+9.1%) |
| Jun 2024 | - | $14.00 M(+3.4%) |
| Mar 2024 | - | $13.54 M(-4.6%) |
| Dec 2023 | $14.18 M(+152.6%) | $14.18 M(+37.3%) |
| Sep 2023 | - | $10.33 M(+26.5%) |
| Jun 2023 | - | $8.16 M(+55.9%) |
| Mar 2023 | - | $5.24 M(-6.7%) |
| Dec 2022 | $5.62 M | $5.62 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.90 M(+0.3%) |
| Jun 2022 | - | $5.88 M(+7.4%) |
| Mar 2022 | - | $5.47 M(+2.1%) |
| Dec 2021 | $5.36 M(+13.8%) | $5.36 M(+21.9%) |
| Sep 2021 | - | $4.40 M(-2.2%) |
| Jun 2021 | - | $4.49 M(-18.3%) |
| Mar 2021 | - | $5.50 M(+16.7%) |
| Dec 2020 | $4.71 M(+234.3%) | $4.71 M |
| Dec 2019 | $1.41 M | - |
FAQ
- What is Candel Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Candel Therapeutics?
- What is Candel Therapeutics annual current liabilities year-on-year change?
- What is Candel Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Candel Therapeutics?
- What is Candel Therapeutics quarterly current liabilities year-on-year change?
What is Candel Therapeutics annual total current liabilities?
The current annual current liabilities of CADL is $14.18 M
What is the all time high annual current liabilities for Candel Therapeutics?
Candel Therapeutics all-time high annual total current liabilities is $14.18 M
What is Candel Therapeutics annual current liabilities year-on-year change?
Over the past year, CADL annual total current liabilities has changed by +$8.57 M (+152.61%)
What is Candel Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CADL is $15.27 M
What is the all time high quarterly current liabilities for Candel Therapeutics?
Candel Therapeutics all-time high quarterly total current liabilities is $15.27 M
What is Candel Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CADL quarterly total current liabilities has changed by +$1.27 M (+9.09%)